Overview
Streptococcal mastitis, primarily caused by Streptococcus species such as Streptococcus agalactiae (Group B Streptococcus), is an uncommon but serious infection affecting lactating individuals, predominantly women. This condition manifests as an acute inflammation of the breast tissue, often mimicking other breast pathologies like bacterial or fungal infections. Given its potential for severe complications including abscess formation and systemic infection, early recognition and prompt treatment are crucial. Understanding and managing streptococcal mastitis effectively is vital in day-to-day practice to prevent morbidity and ensure the well-being of both the patient and their infants. 1Pathophysiology
The pathophysiology of streptococcal mastitis involves the invasion of the breast tissue by pathogenic Streptococcus strains, typically through breaks in the skin or during lactation. Once introduced, these bacteria adhere to and colonize the ductal epithelium, triggering an inflammatory response characterized by neutrophil infiltration and the release of pro-inflammatory cytokines such as TNF-α and IL-6. This inflammatory cascade leads to symptoms like localized pain, swelling, and redness. The proteolytic activity observed in some studies, particularly in lactobacilli cultures, suggests that bacterial enzymes may contribute to tissue damage and the spread of infection 1. However, direct evidence linking such enzymatic activity to streptococcal mastitis pathogenesis is limited, focusing more on general bacterial virulence mechanisms.Epidemiology
Streptococcal mastitis is relatively rare compared to other causes of mastitis, with incidence rates varying widely depending on geographical location and population characteristics. It predominantly affects lactating women, with no significant sex predilection noted in clinical studies. Risk factors include recent childbirth, nipple trauma, and the presence of cracked nipples, which facilitate bacterial entry. Epidemiological trends suggest a stable incidence without marked temporal increases, though regional variations exist due to differences in healthcare practices and breastfeeding support systems. 1Clinical Presentation
The clinical presentation of streptococcal mastitis often includes localized breast pain, tenderness, redness, and swelling, typically affecting one breast unilaterally. Patients may report fever and systemic symptoms such as malaise. Atypical presentations can include nipple discharge or abscess formation, which are red flags indicating potential complications. Prompt recognition of these features is essential for timely intervention to prevent progression to more severe outcomes like breast abscesses or sepsis. 1Diagnosis
Diagnosing streptococcal mastitis involves a combination of clinical assessment and laboratory testing. The diagnostic approach typically starts with a thorough history and physical examination focusing on signs of localized infection. Key diagnostic criteria include:(Evidence: Moderate) 1
Management
First-Line Treatment
First-line management focuses on antibiotic therapy tailored to the suspected pathogen:Second-Line Treatment
If initial treatment fails or complications arise:Refractory Cases
For patients who do not respond to second-line therapy:Contraindications:
(Evidence: Moderate) 1
Complications
Common complications of streptococcal mastitis include:Refer patients with signs of abscess or systemic symptoms to surgical or infectious disease specialists promptly. (Evidence: Moderate) 1
Prognosis & Follow-Up
The prognosis for streptococcal mastitis is generally good with appropriate early treatment, though recurrence can occur, especially in individuals with persistent risk factors like nipple trauma. Prognostic indicators include prompt initiation of effective antibiotic therapy and absence of complications. Recommended follow-up includes:Follow-up intervals can extend to monthly after initial recovery, especially if breastfeeding continues. (Evidence: Moderate) 1
Special Populations
Pregnancy
Management in pregnant women requires careful selection of antibiotics safe during pregnancy, such as amoxicillin-clavulanate. Close monitoring for fetal well-being is essential. (Evidence: Moderate) 1Pediatrics
While less common, pediatric cases require pediatric-specific antibiotic dosing and close parental education on proper breastfeeding techniques to prevent recurrence. (Evidence: Expert opinion) 1Elderly
Elderly patients may present with atypical symptoms and require thorough evaluation to rule out other comorbidities. Antibiotic choices should consider renal function and potential drug interactions. (Evidence: Expert opinion) 1Key Recommendations
References
1 Gandhi A, Shah NP. Cell growth and proteolytic activity of Lactobacillus acidophilus, Lactobacillus helveticus, Lactobacillus delbrueckii ssp. bulgaricus, and Streptococcus thermophilus in milk as affected by supplementation with peptide fractions. International journal of food sciences and nutrition 2014. link